| Dr Michelle S Susco, MD | |
|
1830 Town Center Dr, Suite # 205, Reston, VA 20190-3292 | |
| (703) 435-3636 | |
| (703) 435-9145 |
| Full Name | Dr Michelle S Susco |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1830 Town Center Dr, Reston, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760443691 | NPI | - | NPPES |
| 6709508 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0101050668 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle S Susco, MD 1830 Town Center Dr, Suite # 205, Reston, VA 20190-3292 Ph: (703) 435-3636 | Dr Michelle S Susco, MD 1830 Town Center Dr, Suite # 205, Reston, VA 20190-3292 Ph: (703) 435-3636 |
News Archive
Mirati Therapeutics, Inc. today announced that the first patient with Non-Small Cell Lung Cancer (NSCLC) has been dosed in a Phase 1b clinical trial of MGCD265 in selected patients exhibiting genetic alterations of MET or Axl.
According to a new study the addition of an experimental immunotherapy drug to the standard regimen of care extended the lives and decreased the risk of a disease recurrence in children with high-risk neuroblastoma. This tumor most frequently originates in one of the adrenal glands, but can also develop in nerve tissues in the neck, chest, abdomen, or pelvis. It forms 12 percent of cancer-related deaths in children under the age of 15 and half of patients with this type of malignancy have the high-risk form.
ETEX Corporation, an advanced biomaterials company, announced today additional FDA 510(k) cleared indications for EquivaBone®. EquivaBone was the first FDA cleared hard-setting osteoinductive material and is the only osteoinductive bone graft substitute that provides a continuous nanocrystalline calcium phosphate scaffold.
According to a new study published in the journal Gastroenterology, immune cells of a certain kind which regulate inflammatory processes and even help restore normal gut function after inflammation could be of great use to treat children with inflammatory bowel disease (IBD).
Nutritious school lunches and a ban on sweets, buns and sweetened drinks in school is a good strategy for reducing the risk of obesity in children, reveals a new study from Swedish medical university Karolinska Institutet.
› Verified 3 days ago
Emily A Lozano, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1850 Town Center Pkwy, Reston Hospital Center, Reston, VA 20190 Phone: 703-689-9037 Fax: 703-689-9109 | |
Niloofar Arbabi, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1760 Reston Pkwy, Suite 400, Reston, VA 20190 Phone: 703-467-9444 Fax: 703-467-8484 | |
Ruth Avigan Mann, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11130 Sunrise Valley Dr, Suite #150, Reston, VA 20191 Phone: 703-262-0100 Fax: 703-262-0333 | |
Dr. Damien M Parker, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1890 Metro Center Dr, Reston, VA 20190 Phone: 703-709-1500 Fax: 703-709-1625 | |
Dr. Gail Carome, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11130 Sunrise Valley Dr, Suite 150, Reston, VA 20191 Phone: 703-262-0100 Fax: 703-262-0333 | |
Geetanjali Jain, MSN, DNP, FNP-BC Pediatrics Medicare: Medicare Enrolled Practice Location: 11800 Sunrise Valley Dr Ste 700, Reston, VA 20191 Phone: 703-834-1473 Fax: 703-318-7463 | |
Dr. Mindy Stern, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11349 Sunset Hills Rd, Reston, VA 20190 Phone: 703-327-0075 |